|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
AU6014094A
(en)
|
1992-12-02 |
1994-06-22 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
KR100356615B1
(ko)
|
1993-07-13 |
2003-04-03 |
아방티 파르마 소시에테 아노님 |
결함아데노바이러스벡터및유전자치료에서그의사용
|
|
EP0932694A2
(en)
|
1996-09-11 |
1999-08-04 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Aav4 vector and uses thereof
|
|
CA2300957A1
(en)
|
1997-08-15 |
1999-02-25 |
Rubicon Laboratory, Inc. |
Retrovirus and viral vectors
|
|
US6399383B1
(en)
|
1997-10-28 |
2002-06-04 |
Maxygen, Inc. |
Human papilloma virus vectors
|
|
DE69922934T2
(de)
|
1998-03-20 |
2005-12-08 |
The Trustees Of The University Of Pennsylvania |
Zusammensetzungen und Verfahren zur helfer-freien Herstellung von rekombinanten Adeno-assoziierten Viren
|
|
AU1441900A
(en)
|
1998-10-01 |
2000-04-17 |
University Of Southern California |
Gene delivery system and methods of use
|
|
US6156514A
(en)
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
|
US6410013B1
(en)
|
1999-01-25 |
2002-06-25 |
Musc Foundation For Research Development |
Viral vectors for use in monitoring HIV drug resistance
|
|
WO2000072886A1
(en)
|
1999-05-26 |
2000-12-07 |
Dana-Farber Cancer Institute, Inc. |
Episomally replicating lentiviral vectors
|
|
US7125705B2
(en)
|
2000-04-28 |
2006-10-24 |
Genzyme Corporation |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
EP1282449A2
(en)
|
2000-05-12 |
2003-02-12 |
The Regents Of The University Of California |
Treatment of human papillomavirus (hpv)-infected cells
|
|
WO2001091802A1
(en)
|
2000-05-30 |
2001-12-06 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
|
NO314588B1
(no)
*
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
|
US20030119770A1
(en)
|
2001-08-02 |
2003-06-26 |
Zhennan Lai |
Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
|
|
AU2002323270A1
(en)
|
2001-08-18 |
2003-03-03 |
Myriad Genetics, Inc |
Composition and method for treating hiv infection
|
|
US7737124B2
(en)
|
2001-09-13 |
2010-06-15 |
California Institute Of Technology |
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
|
|
AU2002363465A1
(en)
|
2001-10-25 |
2003-05-19 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
|
|
US20070203333A1
(en)
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
WO2003079757A2
(en)
|
2002-03-20 |
2003-10-02 |
Massachusetts Institute Of Technology |
Hiv therapeutic
|
|
AU2003237159A1
(en)
|
2002-04-30 |
2003-11-17 |
University Of Florida |
Treatment for phenylketonuria
|
|
US7811580B2
(en)
|
2002-05-07 |
2010-10-12 |
Novartis Vaccines & Diagnostics, Inc. |
Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
|
|
US20040161412A1
(en)
|
2002-08-22 |
2004-08-19 |
The Cleveland Clinic Foundation |
Cell-based VEGF delivery
|
|
EP1545204B1
(en)
|
2002-09-06 |
2016-08-10 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
|
|
EP1567539B1
(en)
|
2002-11-04 |
2009-09-23 |
University of Massachusetts |
Allele-specific rna interference
|
|
AU2003283174A1
(en)
|
2002-12-11 |
2004-06-30 |
Cytos Biotechnology Ag |
Method for protein production
|
|
DK1623017T3
(da)
|
2003-05-08 |
2011-01-10 |
Life Technologies Corp |
Frembringelse og isolering af antigenspecifikke T-celler
|
|
US20060246520A1
(en)
|
2003-05-23 |
2006-11-02 |
Institut National De La Sante Et De La Recherche Medicale |
Gamma delta t cell-mediated therapy
|
|
WO2005005644A1
(en)
|
2003-07-11 |
2005-01-20 |
Cytos Biotechnology Ag |
Gene expression system
|
|
US20050019927A1
(en)
|
2003-07-13 |
2005-01-27 |
Markus Hildinger |
DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER
|
|
US20050138677A1
(en)
|
2003-09-16 |
2005-06-23 |
Pfister Herbert J. |
Transgenic animal model for the treatment of skin tumors
|
|
EP1678292A4
(en)
|
2003-09-18 |
2008-05-07 |
Univ Emory |
IMPROVED MVA VACCINES
|
|
WO2005033282A2
(en)
|
2003-10-01 |
2005-04-14 |
Pharmacia & Upjohn Company Llc |
Polyamide compositions and therapeutic methods for treatment of human papilloma virus
|
|
US20080039413A1
(en)
*
|
2003-10-21 |
2008-02-14 |
Morris David W |
Novel compositions and methods in cancer
|
|
WO2005051927A1
(ja)
|
2003-11-26 |
2005-06-09 |
Kureha Corporation |
Hiv-1感染末梢血単核球の刺激培養によるcd4陽性ｔ細胞の培養方法、及びhiv-1の増殖阻害剤
|
|
WO2005081911A2
(en)
|
2004-02-25 |
2005-09-09 |
Dana-Farber Cancer Institute, Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5α
|
|
JP2007527240A
(ja)
|
2004-03-01 |
2007-09-27 |
マサチューセッツ インスティテュート オブ テクノロジー |
アレルギー性鼻炎および喘息のためのＲＮＡｉベースの治療
|
|
TWI439284B
(zh)
|
2004-04-09 |
2014-06-01 |
Abbvie Biotechnology Ltd |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
US20080227736A1
(en)
|
2004-06-03 |
2008-09-18 |
Regents Of The University Of California, |
Targeting Pseudotyped Retroviral Vectors
|
|
WO2006012221A2
(en)
|
2004-06-25 |
2006-02-02 |
The Regents Of The University Of California |
Target cell-specific short interfering rna and methods of use thereof
|
|
CA2576925C
(en)
|
2004-08-16 |
2013-12-10 |
The Cbr Institute For Biomedical Research, Inc. |
Method of delivering rna interference and uses thereof
|
|
EP1802641B8
(en)
|
2004-10-08 |
2012-03-07 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
|
|
EP1647595A1
(en)
*
|
2004-10-15 |
2006-04-19 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Nucleic acids against viruses, in particular HIV
|
|
WO2006048215A1
(en)
|
2004-11-02 |
2006-05-11 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof
|
|
US7790446B2
(en)
|
2005-02-11 |
2010-09-07 |
Kosagen Cell Factory Oü |
Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
|
|
CN101160055A
(zh)
|
2005-02-16 |
2008-04-09 |
莱蒂恩公司 |
慢病毒载体及其用途
|
|
MX2007010008A
(es)
|
2005-02-16 |
2008-01-18 |
Lentigen Corp |
Vectores lentivirales y su uso.
|
|
SG162726A1
(en)
|
2005-05-27 |
2010-07-29 |
San Raffaele Centro Fond |
Gene vector comprising mi-rna
|
|
US20070032443A1
(en)
|
2005-08-02 |
2007-02-08 |
Jaeseob Kim |
Therapy for Alzheimer's disease
|
|
WO2007015122A1
(en)
|
2005-08-02 |
2007-02-08 |
Genexel, Inc. |
Therapy for alzheimer’s disease
|
|
US20070105835A1
(en)
|
2005-11-07 |
2007-05-10 |
Kazantsev Aleksey G |
Compositions and methods for modulating poly(ADP-ribose) polymerase activity
|
|
WO2007133674A2
(en)
|
2006-05-12 |
2007-11-22 |
Lentigen Corporation |
Lentiviral vector compositions, methods and applications
|
|
WO2007149476A2
(en)
|
2006-06-19 |
2007-12-27 |
Trustees Of Columbia University In The City Of New York |
Assays for non-apoptotic cell death and uses thereof
|
|
US20080003225A1
(en)
|
2006-06-29 |
2008-01-03 |
Henri Vie |
Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
|
|
US8124752B2
(en)
|
2006-07-10 |
2012-02-28 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the MYC gene
|
|
EP1878440A1
(en)
|
2006-07-13 |
2008-01-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
|
|
US20090203694A1
(en)
|
2006-07-26 |
2009-08-13 |
Timothy Brian Hurley |
Inhibitors of undecaprenyl pyrophosphate synthase
|
|
US20080199961A1
(en)
|
2006-08-25 |
2008-08-21 |
Avi Biopharma, Inc. |
ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS
|
|
WO2008100292A2
(en)
|
2006-10-16 |
2008-08-21 |
Genelux Corporation |
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
|
|
US8338101B2
(en)
*
|
2007-01-23 |
2012-12-25 |
Virco Bvba |
Method for designing a drug regime for HIV-infected patients
|
|
CA2682694A1
(en)
|
2007-04-12 |
2008-10-23 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
|
|
US20080293142A1
(en)
|
2007-04-19 |
2008-11-27 |
The Board Of Regents For Oklahoma State University |
Multiple shRNA Expression Vectors and Methods of Construction
|
|
EP2008656A1
(en)
|
2007-06-28 |
2008-12-31 |
Bergen Teknologioverforing AS |
Compositions for the treatment of hyperphenylalaninemia
|
|
US20110177155A1
(en)
*
|
2007-08-21 |
2011-07-21 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
|
AU2008348260A1
(en)
|
2008-01-16 |
2009-07-23 |
Opal Therapeutics Pty Ltd |
Immunomodulating compositions and uses therefor
|
|
EP2090659A1
(en)
|
2008-02-14 |
2009-08-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Infectious particle, process for its preparation and use thereof
|
|
GB0802754D0
(en)
|
2008-02-14 |
2008-03-26 |
Inst Superiore Di Sanito |
Antisense RNA targetting CXCR4
|
|
US20110142880A1
(en)
|
2008-03-28 |
2011-06-16 |
Franck Yann Lemiale |
Lentivirus-based immunogenic vectors
|
|
GB0810209D0
(en)
|
2008-06-04 |
2008-07-09 |
Cambridge Entpr Ltd |
Pluripotency associated epigenetic factor
|
|
KR101522442B1
(ko)
|
2008-06-16 |
2015-05-21 |
폴리플러스 배터리 컴퍼니 |
수성 리튬/공기 전지 셀
|
|
US8629334B2
(en)
|
2008-07-16 |
2014-01-14 |
University Of Florida Research Foundation, Inc. |
Viral-based transient-expression vector system for trees
|
|
WO2010022195A2
(en)
|
2008-08-20 |
2010-02-25 |
Virxsys Corporation |
Non-integrating lenti/adeno-associated virus hybrid vector system
|
|
EP2342321B1
(en)
|
2008-09-17 |
2018-04-11 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
CA2779436A1
(en)
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
Light targeting molecules and uses thereof
|
|
WO2010051521A1
(en)
|
2008-10-31 |
2010-05-06 |
Lentigen Corporation |
Cell therapy product for the treatment of hiv infection
|
|
US20110263001A1
(en)
|
2008-11-14 |
2011-10-27 |
Life Technologies Corporation |
Compositions and Methods for Engineering Cells
|
|
EP2191834A1
(en)
|
2008-11-26 |
2010-06-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions and methods for treating retrovirus infections
|
|
WO2010117974A2
(en)
|
2009-04-09 |
2010-10-14 |
Stemcyte Inc. |
Hiv-resistant stem cells and uses thereof
|
|
SG175127A1
(en)
|
2009-04-13 |
2011-11-28 |
Apceth Gmbh & Co Kg |
Engineered mesenchymal stem cells and method of using same to treat tumors
|
|
EP2425001A4
(en)
|
2009-04-30 |
2012-11-14 |
Univ California |
ANTI-HIV COMBINATION VECTORS, TARGETING VECTORS AND METHOD OF USE
|
|
US20120201794A1
(en)
|
2009-07-15 |
2012-08-09 |
Calimmune Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
|
SG178909A1
(en)
|
2009-10-08 |
2012-04-27 |
Bavarian Nordic As |
Generation of a broad t-cell response in humans against hiv
|
|
WO2011066578A1
(en)
|
2009-11-30 |
2011-06-03 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
|
CN101805750B
(zh)
|
2009-12-29 |
2011-11-30 |
浙江大学 |
法呢基焦磷酸合成酶rna干扰重组慢病毒载体构建及用途
|
|
CA2790426A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Emory University |
Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
|
|
WO2011119942A1
(en)
|
2010-03-25 |
2011-09-29 |
Vistagen Therapeutics, Inc. |
Induction of ips cells using transient episomal vectors
|
|
US20130090371A1
(en)
|
2010-04-20 |
2013-04-11 |
President And Fellows Of Harvard College |
Methods and compositions for inhibition of beta2-adrenergic receptor degradation
|
|
ES2699630T3
(es)
|
2010-04-23 |
2019-02-12 |
Cold Spring Harbor Laboratory |
Novedosos ARNhc diseñados estructuralmente
|
|
EP2575894B1
(en)
|
2010-05-28 |
2015-02-25 |
Oxford Biomedica (UK) Ltd |
Delivery of lentiviral vectors to the brain
|
|
WO2012020757A1
(ja)
|
2010-08-10 |
2012-02-16 |
タカラバイオ株式会社 |
細胞集団の製造方法
|
|
EP2625294A4
(en)
|
2010-10-07 |
2014-03-26 |
Univ Columbia |
PROCESS FOR TREATING TUMORS WITH A P53 MUTATION
|
|
WO2012061075A2
(en)
|
2010-10-25 |
2012-05-10 |
The Regents Of The University Of California |
Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
|
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス（ａａｖ）ベクターを用いたタンパク質の送達
|
|
EP2696894B1
(en)
|
2011-04-13 |
2017-11-01 |
Immunicum AB |
Method for priming of t cells
|
|
EP3318634A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating diseases involving dominant-negative or gain of function mutations
|
|
HK1202434A1
(en)
|
2011-11-22 |
2015-10-02 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
US9745631B2
(en)
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
|
MX367842B
(es)
|
2012-02-07 |
2019-09-09 |
Global Bio Therapeutics Inc |
Método compartimentado de administración de ácidos nucleicos y composiciones y usos del mismo.
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
US20150174235A1
(en)
|
2012-06-06 |
2015-06-25 |
Bionor Immuno As |
Vaccine
|
|
WO2014016817A2
(en)
|
2012-07-17 |
2014-01-30 |
Universite De Geneve |
Nucleic acids for down-regulation of gene expression
|
|
US10233495B2
(en)
*
|
2012-09-27 |
2019-03-19 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
|
JP6391582B2
(ja)
|
2012-11-13 |
2018-09-19 |
コディアック バイオサイエンシズ インコーポレイテッド |
治療剤の送達方法
|
|
CA2892448A1
(en)
|
2012-12-05 |
2014-06-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of metabolic disorders
|
|
US9642921B2
(en)
|
2012-12-20 |
2017-05-09 |
Tocagen Inc. |
Cancer combination therapy and recombinant vectors
|
|
WO2014117050A2
(en)
|
2013-01-26 |
2014-07-31 |
Mirimus, Inc. |
Modified mirna as a scaffold for shrna
|
|
CN103184224A
(zh)
|
2013-04-03 |
2013-07-03 |
衡阳师范学院 |
一种抗艾滋病病毒感染的三联miRNA及构建方法
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
WO2014187881A1
(en)
|
2013-05-21 |
2014-11-27 |
Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. |
Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy
|
|
WO2015017755A1
(en)
|
2013-08-02 |
2015-02-05 |
The Regents Of The University Of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
|
WO2015042308A2
(en)
|
2013-09-18 |
2015-03-26 |
City Of Hope |
Rna-based hiv inhibitors
|
|
EA201992208A1
(ru)
|
2013-10-22 |
2020-07-31 |
Транслейт Био, Инк. |
ЛЕЧЕНИЕ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
|
|
JP2016536021A
(ja)
|
2013-11-07 |
2016-11-24 |
エディタス・メディシン，インコーポレイテッド |
ＣＲＩＳＰＲ関連方法および支配ｇＲＮＡのある組成物
|
|
EP2878674A1
(en)
|
2013-11-28 |
2015-06-03 |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) |
Stable episomes based on non-integrative lentiviral vectors
|
|
GB201322091D0
(en)
|
2013-12-13 |
2014-01-29 |
Cambridge Entpr Ltd |
Modified serpins for the treatment of bleeding disorders
|
|
ES2995052T3
(en)
|
2014-04-23 |
2025-02-05 |
Juno Therapeutics Inc |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
PL3689899T3
(pl)
|
2014-04-25 |
2022-01-31 |
2Seventy Bio, Inc. |
Chimeryczne receptory antygenowe promotora mnd
|
|
DK3546585T3
(da)
|
2014-04-25 |
2025-11-03 |
Genethon |
Nukleinsyrer med en modificeret intron til brug i behandlingen af hyperbilirubinæmi
|
|
EP3186365A4
(en)
|
2014-08-29 |
2018-04-25 |
Immunomedics, Inc. |
Identification of cancer genes by in-vivo fusion of human cancer cells and animal cells
|
|
US10174354B2
(en)
|
2014-09-22 |
2019-01-08 |
Nexttobe Ab |
Recombinant Phe-free proteins for use in the treatment of phenylketonuria
|
|
MA40783A
(fr)
*
|
2014-10-03 |
2017-08-08 |
Los Alamos Nat Security Llc |
Vaccins contre le vih comprenant un ou plusieurs antigènes episensus de population
|
|
AU2015329696A1
(en)
|
2014-10-10 |
2017-04-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods to eliminate cancer stem cells by targeting CD47
|
|
US10968451B2
(en)
|
2014-10-14 |
2021-04-06 |
Texas Tech University System |
Multiplexed shRNAs and uses thereof
|
|
WO2016069518A2
(en)
*
|
2014-10-27 |
2016-05-06 |
International Aids Vaccine Initiative |
Genetically stable replication competent sendai virus vector(s) containing and expressing optimized hiv genes
|
|
WO2016069716A1
(en)
|
2014-10-30 |
2016-05-06 |
The Scripps Research Institute |
Compositions and methods comprising tyrosyl-trna synthetases and resveratrol compounds
|
|
CN108026543A
(zh)
|
2015-05-18 |
2018-05-11 |
卡琳缪恩股份有限公司 |
用于hiv的治疗的基因疗法及其用途
|
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
|
US20180161455A1
(en)
|
2015-06-10 |
2018-06-14 |
American Gene Technologies International, Inc. |
Non-integrating viral delivery system and methods of use therof
|
|
WO2017007994A1
(en)
*
|
2015-07-08 |
2017-01-12 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
EP3334820B1
(en)
|
2015-08-13 |
2024-05-15 |
Beihao Stem Cell and Regenerative Medicine Research Institute Co., Ltd. |
Induced extended pluripotent stem cells, methods of making and using
|
|
CN105112370B
(zh)
|
2015-08-25 |
2019-02-05 |
杭州优善生物科技有限公司 |
一种体外刺激外周血γδT细胞高效增殖的方法及其应用
|
|
WO2017053556A1
(en)
|
2015-09-22 |
2017-03-30 |
The Trustees Of The University Of Pennsylvania |
Method of redirecting t cells to treat hiv infection
|
|
WO2017068077A1
(en)
|
2015-10-20 |
2017-04-27 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and products for genetic engineering
|
|
WO2017100551A1
(en)
|
2015-12-09 |
2017-06-15 |
Alexion Pharmaceuticals, Inc. |
HETEROLOGOUS UTR SEQUENCES FOR ENHANCED mRNA EXPRESSION
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
IL310925A
(en)
|
2016-01-15 |
2024-04-01 |
American Gene Tech Int Inc |
Methods and compositons for the activation of gamma-delta t-cells
|
|
US10888613B2
(en)
|
2016-02-08 |
2021-01-12 |
American Gene Technologies International Inc. |
Method of producing cells resistant to HIV infection
|
|
WO2017156311A2
(en)
|
2016-03-09 |
2017-09-14 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
|
US20190117799A1
(en)
|
2016-04-01 |
2019-04-25 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
|
WO2017213697A1
(en)
|
2016-06-08 |
2017-12-14 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
WO2018009246A1
(en)
|
2016-07-08 |
2018-01-11 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
US11583562B2
(en)
|
2016-07-21 |
2023-02-21 |
American Gene Technologies International Inc. |
Viral vectors for treating Parkinson's disease
|
|
US10772887B2
(en)
|
2016-08-03 |
2020-09-15 |
Kagoshima University |
Anti-HTLV-1 drug and therapeutic agent for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
|
|
EP3562494A4
(en)
|
2016-12-30 |
2020-08-19 |
The Trustees Of The University Of Pennsylvania |
GENE THERAPY FOR THE TREATMENT OF PHENYLKETONURIS
|
|
US20200384021A1
(en)
|
2017-01-09 |
2020-12-10 |
American Gene Technologies International Inc. |
Hiv immunotherapy with no pre-immunization step
|
|
CN110621322A
(zh)
|
2017-02-08 |
2019-12-27 |
达纳-法伯癌症研究所有限公司 |
用异双功能性化合物进行的可调节的内源性蛋白质降解
|
|
CA3057142A1
(en)
|
2017-04-03 |
2018-10-11 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
CN110770338A
(zh)
|
2017-06-16 |
2020-02-07 |
美国基因技术国际有限公司 |
由人γ-δ T细胞激活肿瘤细胞毒性的方法和组合物
|
|
KR20200057766A
(ko)
|
2017-10-02 |
2020-05-26 |
아메리칸 진 테크놀로지스 인터내셔널 인코포레이티드 |
페닐케톤뇨증을 치료하기 위한 프로모터 및 인핸서 조합을 포함하는 벡터
|
|
JP2021519069A
(ja)
|
2018-03-27 |
2021-08-10 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
遺伝子改変リンパ球の製造方法
|
|
US20210275589A1
(en)
|
2018-07-13 |
2021-09-09 |
Nanjing Legend Biotech Co. Ltd. |
Co-receptor systems for treating infectious diseases
|
|
JP2022506515A
(ja)
|
2018-11-05 |
2022-01-17 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
制御性ｒｎａを発現させるためのベクターシステム
|
|
US20220162643A1
(en)
|
2019-05-31 |
2022-05-26 |
American Gene Technologies International Inc. |
Optimized phenylananine hydroxylase expression
|